Prognostic value of copeptin in patients with acute stroke

References

• De Marchis GM, Katan M, Weck A, et al. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study. Int J Stroke 2013;8(3):214-18
   PubMedGoogle Scholar
• Nickel CH, Bingisser R, Morgenthaler NG. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 2012;10:7
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52(1):112-19
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Muller B, Struck J, et al. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007;28(2):219-26
   PubMed Web of Science ®Google Scholar
• Khan SQ, Dhillon OS, O’Brien RJ, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007;115(16):2103-10
   PubMed Web of Science ®Google Scholar
• Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007;131(4):1058-67
   PubMed Web of Science ®Google Scholar
• Muller B, Morgenthaler N, Stolz D, et al. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007;37(2):145-52
   PubMed Web of Science ®Google Scholar
• Dong XQ, Huang M, Yang SB, et al. Copeptin is associated with mortality in patients with traumatic brain injury. J Trauma 2011;71(5):1194-8
   PubMedGoogle Scholar
• Katan M, Fluri F, Morgenthaler NG, et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009;66(6):799-808
   PubMed Web of Science ®Google Scholar
• Yu WH, Wang WH, Dong XQ, et al. Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage. Clin Chim Acta 2014;433:174-8
   PubMedGoogle Scholar
• Fung C, De Marchis GM, Katan M, et al. Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. PLoS One 2013;8(1):e53191
   Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25(9):603-5
   PubMed Web of Science ®Google Scholar
• Katan M, Muller B, Christ-Crain M. Copeptin: a new and promising diagnostic and prognostic marker. Crit Care 2008;12(2):117
   PubMed Web of Science ®Google Scholar
• Fluri F, Morgenthaler NG, Mueller B, et al. Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke. PLoS One 2012;7(10):e48309
   PubMed Web of Science ®Google Scholar
• Li Y, Yu D, Xie Y. Plasma copeptin levels in elderly victims of massive cerebral infarction and its relationship to early death. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2012;37:586-90
   PubMedGoogle Scholar
• Morgenthaler NG, Struck J, Jochberger S, Dunser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008;19(2):43-9
   PubMed Web of Science ®Google Scholar
• Miao Y, Liao JK. Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother 2014;14(2):173-85
   PubMed Web of Science ®Google Scholar
• Dobsa L, Edozien KC. Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochemia medica 2013;23(2):172-90
   Web of Science ®Google Scholar
• Enhorning S, Wang TJ, Nilsson PM, et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 2010;121(19):2102-8
   PubMedGoogle Scholar
• von Haehling S, Stojakovic T, Bigalke B. Copeptin–a novel marker in acute myocardial infarction. Clin Chem 2012;58(1):307-9. author reply 309-311
   PubMedGoogle Scholar
• Lagi A, Cuomo A, Veneziani F, Cencetti S. Copeptin: a blood test marker of syncope. Int J Clin Pract 2013;67(6):512-15
   PubMedGoogle Scholar
• Bar-Shalom D, Poulsen MK, Rasmussen LM, et al. Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients. Diab Vasc Dis Res 2014;11(6):448-50
   PubMedGoogle Scholar
• Iversen K, Gotze JP, Dalsgaard M, et al. Risk stratification in emergency patients by copeptin. BMC Med 2014;12:80
   PubMedGoogle Scholar
• Maravic-Stojkovic V, Lausevic-Vuk LJ, Obradovic M, et al. Copeptin level after carotid endarterectomy and perioperative stroke. Angiology 2014;65(2):122-9
   PubMedGoogle Scholar
• Meisel A, Meisel C, Harms H, et al. Predicting post-stroke infections and outcome with blood-based immune and stress markers. Cerebrovasc Dis 2012;33(6):580-8
   PubMedGoogle Scholar
• De Marchis GM, Katan M, Weck A, et al. Validation of copeptin as prognostic marker in ischaemic stroke. J Neurol 2010;257(Suppl 1):S123
   Google Scholar
• Zhang JL, Yin CH, Zhang Y, et al. Plasma copeptin and long-term outcomes in acute ischemic stroke. Acta Neurol Scand 2013;128(6):372-80
   PubMed Web of Science ®Google Scholar
• Dong X, Tao DB, Wang YX, et al. Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study. Neurol Sci 2013;34(9):1591-5
   PubMed Web of Science ®Google Scholar
• Tu WJ, Dong X, Zhao SJ, et al. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. J Neuroendocrinol 2013;25(9):771-8
   PubMed Web of Science ®Google Scholar
• Tu WJ, Chen H, Cui LH. Prognostic value of copeptin in patients with acute ischemic stroke. Iran J Neurol 2011;10(3-4):58
   PubMedGoogle Scholar
• Wei ZJ, Ou YQ, Li X, Li H. The 90-day prognostic value of copeptin in acute intracerebral hemorrhage. Neurol Sci 2014;35(11):1673-9
   PubMedGoogle Scholar
• Zhang X, Lu XM, Huang LF, Ye H. Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage. Peptides 2012;33(2):336-41
   PubMed Web of Science ®Google Scholar
• Dong XQ, Huang M, Yu WH, et al. Change in plasma copeptin level after acute spontaneous basal ganglia hemorrhage. Peptides 2011;32(2):253-7
   PubMed Web of Science ®Google Scholar
• Zhang A, Li J, Li X, et al. The prognostic value of copeptin for acute intracerebral hemorrhage patients. Exp Ther Med 2013;5(2):467-70
   PubMed Web of Science ®Google Scholar
• Zweifel C, Katan M, Schuetz P, et al. Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 2010;10:34
   PubMed Web of Science ®Google Scholar
• Zhu XD, Chen JS, Zhou F, et al. Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Crit Care 2011;15(6):R288
   PubMed Web of Science ®Google Scholar
• Papa L, Robertson CS, Wang KK, et al. Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury. Neurocrit Care 2014. [Epub ahead of print]
   Google Scholar
• Cheng F, Yuan Q, Yang J, et al. The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis. PLoS One 2014;9(9):e106680
   PubMed Web of Science ®Google Scholar
• Daoud H, Alharfi I, Alhelali I, et al. Brain injury biomarkers as outcome predictors in pediatric severe traumatic brain injury. Neurocrit Care 2014;20(3):427-35
   PubMedGoogle Scholar
• Greenberg SM, Al-Shahi Salman R, Biessels GJ, et al. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol 2014;13(4):419-28
   PubMedGoogle Scholar
• Kim SJ, Moon GJ, Bang OY. Biomarkers for stroke. J Stroke 2013;15(1):27-37
   PubMed Web of Science ®Google Scholar
• Whiteley W, Tian Y, Jickling GC. Blood biomarkers in stroke: research and clinical practice. Int J Stroke 2012;7(5):435-9
   PubMedGoogle Scholar
• Urwyler SA, Schuetz P, Fluri F, et al. Prognostic value of copeptin: One-year outcome in patients with acute stroke. Stroke 2010;41(7):1564-7
   PubMed Web of Science ®Google Scholar